Karpus discloses 1.28% Aimei Health (NASDAQ: AFJK) stake in 13G/A

Rhea-AI Filing Summary

Karpus Management, Inc., doing business as Karpus Investment Management, has filed an amended Schedule 13G reporting its beneficial ownership in Aimei Health Technology Co., Ltd. common shares. As of the event date of 12/31/2025, Karpus reports beneficial ownership of 78,075 common shares, representing 1.28% of the class.

Karpus, a New York-based registered investment adviser, reports sole voting and sole dispositive power over all 78,075 shares, with no shared voting or dispositive power. The shares are held in accounts managed by Karpus, and the firm certifies they were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Aimei Health Technology.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Aimei Health Technology Co., Ltd.

(Name of Issuer)

Common

(Title of Class of Securities)

G01341109

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G01341109

1

Names of Reporting Persons

KARPUS MANAGEMENT, INC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 78,075.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 78,075.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

78,075.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.28 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aimei Health Technology Co., Ltd.
(b)	Address of issuer's principal executive offices: 10 East 53rd Street, Suite 3001, New York, NY 10022
Item 2.
(a)	Name of person filing: This statement is being filed by Karpus Management, Inc., d/b/a Karpus Investment Management ("Karpus" or the "Reporting Person"). Karpus is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940. Karpus is controlled by City of London Investment Group plc ("CLIG"), which is listed on the London Stock Exchange. However, in accordance with SEC Release No. 34-39538 (January 12, 1998), effective informational barriers have been established between Karpus and CLIG such that voting and investment power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly, attribution of beneficial ownership is not required between Karpus and CLIG. The Shares to which this Schedule 13G relates are owned directly by the accounts managed by Karpus.
(b)	Address or principal business office or, if none, residence: 183 Sully's Trail, Pittsford, New York 14534
(c)	Citizenship: The members of the Karpus Management Committee are US citizens. Karpus is a New York corporation.
(d)	Title of class of securities: Common
(e)	CUSIP No.: G01341109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 78,075.00
(b)	Percent of class: 1.28 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 78,075.00
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 78,075.00
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

KARPUS MANAGEMENT, INC.

Signature:	/s/ Jodi L. Hedberg
Name/Title:	Jodi L. Hedberg / Chief Compliance Officer
Date:	01/07/2026

FAQ

What stake does Karpus Management hold in Aimei Health Technology (AFJK)?

Karpus Management, Inc. reports beneficial ownership of 78,075 common shares of Aimei Health Technology Co., Ltd., representing 1.28% of the outstanding class as of 12/31/2025.

Does Karpus Management have voting control over its AFJK shares?

Karpus reports sole voting power over 78,075 Aimei Health Technology common shares and no shared voting power.

How many Aimei Health Technology (AFJK) shares can Karpus dispose of?

Karpus reports sole dispositive power over 78,075 Aimei Health Technology common shares and no shared dispositive power.

Is Karpus Management’s AFJK position a passive investment?

Yes. Karpus certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Aimei Health Technology.

Who controls Karpus Management and how is beneficial ownership treated?

Karpus is controlled by City of London Investment Group plc, but the filing states that effective informational barriers mean voting and investment power over these shares is exercised by Karpus independently, so beneficial ownership is not attributed between Karpus and CLIG.

Where is Karpus Management located and what is its regulatory status?

Karpus Management, Inc. is a New York corporation with its principal office at 183 Sully's Trail, Pittsford, New York 14534, and is a registered investment adviser under the Investment Advisers Act of 1940.